These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15127428)

  • 1. Comorbidities and the willingness to pay for reducing the risk of a targeted disease: introducing endogenous effort for risk reduction.
    Liu L
    Health Econ; 2004 May; 13(5):493-8. PubMed ID: 15127428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A utility-theoretic approach to the aggregation of willingness to pay measured in decomposed scenarios: development and empirical test.
    Hammerschmidt T; Zeitler HP; Leidl R
    Health Econ; 2004 Apr; 13(4):345-61. PubMed ID: 15067672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using willingness to pay to measure family members' preferences in mental health.
    Mulvaney-Day NE
    J Ment Health Policy Econ; 2005 Jun; 8(2):71-81. PubMed ID: 15998979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of risk representation and scope on willingness to pay for reduced risks: evidence from Tokyo Bay, Japan.
    Zhai G; Suzuki T
    Risk Anal; 2008 Apr; 28(2):513-22. PubMed ID: 18419666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay for reductions in health risks when probabilities are distorted.
    Bleichrodt H; Eeckhoudt L
    Health Econ; 2006 Feb; 15(2):211-4. PubMed ID: 16331723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between reliability and size of willingness-to-pay values: a qualitative insight.
    Smith RD
    Health Econ; 2007 Feb; 16(2):211-6. PubMed ID: 16929470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for reducing fatal risk by improving air quality: a contingent valuation study in Chongqing, China.
    Wang H; Mullahy J
    Sci Total Environ; 2006 Aug; 367(1):50-7. PubMed ID: 16580710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
    Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
    Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
    Byrne MM; O'malley K; Suarez-Almazor ME
    Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
    Carlsson KS; Höjgård S; Lethagen S; Lindgren A; Berntorp E; Lindgren B
    Haemophilia; 2004 Sep; 10(5):527-41. PubMed ID: 15357780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits transfer of willingness to pay estimates and functions for health-risk reductions: a cross-country study.
    Brouwer R; Bateman IJ
    J Health Econ; 2005 May; 24(3):591-611. PubMed ID: 15811545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuation of the risk of SARS in Taiwan.
    Liu JT; Hammitt JK; Wang JD; Tsou MW
    Health Econ; 2005 Jan; 14(1):83-91. PubMed ID: 15386665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
    Franic DM; Pathak DS; Gafni A
    J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of real options on willingness to pay for mortality risk reductions.
    Krüger NA; Svensson M
    J Health Econ; 2009 May; 28(3):563-9. PubMed ID: 19261344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for road safety and estimates of the risk of death: evidence from a Swedish contingent valuation study.
    Andersson H
    Accid Anal Prev; 2007 Jul; 39(4):853-65. PubMed ID: 17292319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of approaches to estimating confidence intervals for willingness to pay measures.
    Hole AR
    Health Econ; 2007 Aug; 16(8):827-40. PubMed ID: 17238222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for health risk reduction in the context of altruism.
    Araña JE; León CJ
    Health Econ; 2002 Oct; 11(7):623-35. PubMed ID: 12369063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subject variation more than values clarification explains the reliability of willingness to pay estimates.
    Shiell A; McIntosh K
    Health Econ; 2008 Feb; 17(2):287-92. PubMed ID: 17619235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP?
    Van Houtven G; Powers J; Jessup A; Yang JC
    Health Econ; 2006 Aug; 15(8):775-95. PubMed ID: 16544361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.